Biotoxin Removal, Charcoal, Clay, Cholestyramine

Biotoxin Removal - Charcoal, Clay & Cholestyramine Combo Research

This page contains educational material primarily about Chronic Inflammatory Response Syndrome due to a water damaged building (CIRS). This is a biotoxin illness that is caused by mold and the interaction between mold, bacteria and chemicals used in building materials. Other biotoxin illnesses have similar signs and symptoms. They are also treated similarly. Some of them are discussed on this site. Additionally, there is imformation on this site about Nutrigenomics and Biotransformational pathways as you really can't treat someone with a biotoxin illness without including analysis and treatment of these pathways. This information is for educational purposes only. Nothing in this text is intended to serve as medical advice. All medical decisions should be made only with the guidance of your own personal medical authority. I am doing my best to get this data up quickly and correctly. If you find errors in this data, please let me know.

Some people are reporting the use of charcoal, clay and cholestyramine together and getting a synergistic effect. I am looking for research using two or more of these toether I will post anything that is relative below. So far, I have found an article looking at the use of charcoal and cholestyramine used seperately and together to lower cholesterol. It appears in this case the use of them together was slightly less useful than the use of cholestyramine by itself. However, 1/2 the amount of cholestyramine is being used which would decrease the cost. The slight lessening of effect may be worthwhile in exchange for a decreased cost of using 1/2 charcoal.

Looking at cholesterol removal is useful as like the mycotoxins, it is bouind to bile and goes through the enterohepatic circulation. Choestyramine is used to bind the bile and remove cholesterol and mycotoxins. In both cases it is through fecal elimination of the bile bound items.

Eur J Clin Pharmacol. 1989;37(3):225-30.
Activated charcoal in the treatment of hypercholesterolaemia: dose-response relationships and comparison with cholestyramine.
Neuvonen PJ1, Kuusisto P, Vapaatalo H, Manninen V.

Abstract
The dose-response relationship of activated charcoal in reducing serum cholesterol was determined and the effects of charcoal and cholestyramine were compared in patients with hypercholesterolaemia. In a cross-over study 7 patients ingested charcoal 4, 8, 16 or 32 g/day, and finally bran, each phase lasting for 3 weeks. Serum total and LDL-cholesterol were decreased (maximum 29% and 41%, respectively) and the ratio of HDL/LDL-cholesterol was increased (maximum 121%) by charcoal in a dose dependent manner. Ten further patients with severe hypercholesterolaemia ingested daily for 3 weeks, in random order, activated charcoal 16 g, cholestyramine 16 g, activated charcoal 8 g + cholestyramine 8 g, or bran. The concentrations of total and LDL-cholesterol were reduced by charcoal (23% and 29%, respectively), cholestyramine (31% and 39%) and their combination (30% and 38%). The ratio of HDL/LDL-cholesterol was increased from 0.13 to 0.23 by charcoal, to 0.29 by cholestyramine, and to 0.25 by their combination. Serum triglycerides were increased by cholestyramine but not by charcoal. Other parameters, including the serum concentrations of vitamin A, E and 25(OH)D3 remained unaffected. The changes in lipids only partly subsided during the 3-week bran phase. In general, the acceptability by the patients and the efficacy of activated charcoal, cholestyramine and their combination were about equal, but there were individual preferences for particular treatments.
PMID: 2612535 [PubMed - indexed for MEDLINE]

This article below is not research on a mix of ingredients, but it does compare clays, cellulose, yeast cell walls and charcoal.

Springer Plus - Open Acess
Evaluation of mycotoxin sequestering agents for aflatoxin and deoxynivalenol: an in vitro approach
Changsu Kong, Seung Youp Shin and Beob Gyun KimEmail author

Abstract
An experiment was conducted to determine the efficacy of mycotoxin sequestering agents for binding or degrading aflatoxin B1 (AFB1) and deoxynivalenol (DON) by an in vitro method. Ten toxin binder products including 5 bentonite clays (bentonite A, B, C, D, and E), 2 cellulose products (cellulose A and B), a yeast cell wall, an activated charcoal, and a mixture product containing minerals, microorganisms, and phytogenic substances were used in this experiment. An in vitro procedure was used to mimic the digestive process in pigs. The binding ability for AFB1 of the cellulose products was less compared with the values of other sequestering products (p < 0.05). The percent adsorption of AFB1 by bentonite clays, cellulose products, yeast cell wall product, activated charcoal product, and the mixture product were 92.5 (average of 5 bentonite products), −13.5 (average of 2 cellulose products), 92.7, 100.2, and 96.6, respectively. The respective values for DON were 3.24, 11.6, 22.9, 14.4, and 4.3. In conclusion, most toxin sequestering agents used in the present study had potential to bind AFB1 rather than DON based on the in vitro study which simulated the pH condition of the gastrointestinal tract of pigs.

Full article found here.

For more on different types of Biotoxin Removers.

If you found this information helpful, I would appreciate your support in keeping the site going. If you would like to donate to my work, I thank you in advance and send you my deep felt gratitude.

Biotoxin/Mold